Your browser doesn't support javascript.
loading
Application of In Vivo Imaging Techniques and Diagnostic Tools in Oral Drug Delivery Research.
Senekowitsch, Stefan; Schick, Philipp; Abrahamsson, Bertil; Augustijns, Patrick; Gießmann, Thomas; Lennernäs, Hans; Matthys, Christophe; Marciani, Luca; Pepin, Xavier; Perkins, Alan; Feldmüller, Maximilian; Sulaiman, Sarah; Weitschies, Werner; Wilson, Clive G; Corsetti, Maura; Koziolek, Mirko.
Afiliação
  • Senekowitsch S; Department of Biopharmaceutics and Pharmaceutical Technology, Center of Drug Absorption and Transport, University of Greifswald, 17489 Greifswald, Germany.
  • Schick P; Department of Biopharmaceutics and Pharmaceutical Technology, Center of Drug Absorption and Transport, University of Greifswald, 17489 Greifswald, Germany.
  • Abrahamsson B; Oral Product Development, Pharmaceutical Technology & Development, Operations, AstraZeneca, 431 83 Gothenburg, Sweden.
  • Augustijns P; Department of Pharmaceutical and Pharmacological Sciences, Drug Delivery and Disposition, KU Leuven, 3000 Leuven, Belgium.
  • Gießmann T; Boehringer Ingelheim Pharma GmbH & Co., KG, 88400 Biberach, Germany.
  • Lennernäs H; Department of Pharmaceutical Biosciences, Translational Drug Discovery and Development, Uppsala University, 752 36 Uppsala, Sweden.
  • Matthys C; Department of Chronic Diseases and Metabolism, KU Leuven, 3000 Leuven, Belgium.
  • Marciani L; Department of Endocrinology, University Hospitals Leuven, 3000 Leuven, Belgium.
  • Pepin X; NIHR Nottingham Biomedical Research Centre, Nottingham University Hospitals NHS Trust, Nottingham NG7 2UH, UK.
  • Perkins A; Nottingham University Hospitals NHS Trust and Translational Medical Sciences, School of Medicine, University of Nottingham, Nottingham NG7 2UH, UK.
  • Feldmüller M; New Modalities and Parenteral Development, Pharmaceutical Technology & Development, Operations, AstraZeneca, Macclesfield SK10 2NA, UK.
  • Sulaiman S; NIHR Nottingham Biomedical Research Centre, Nottingham University Hospitals NHS Trust, Nottingham NG7 2UH, UK.
  • Weitschies W; Radiological Sciences, School of Medicine, University of Nottingham, Nottingham NG7 2UH, UK.
  • Wilson CG; Department of Biopharmaceutics and Pharmaceutical Technology, Center of Drug Absorption and Transport, University of Greifswald, 17489 Greifswald, Germany.
  • Corsetti M; Bayer AG Pharmaceuticals, 13353 Berlin, Germany.
  • Koziolek M; NIHR Nottingham Biomedical Research Centre, Nottingham University Hospitals NHS Trust, Nottingham NG7 2UH, UK.
Pharmaceutics ; 14(4)2022 Apr 06.
Article em En | MEDLINE | ID: mdl-35456635
ABSTRACT
Drug absorption following oral administration is determined by complex and dynamic interactions between gastrointestinal (GI) physiology, the drug, and its formulation. Since many of these interactions are not fully understood, the COST action on "Understanding Gastrointestinal Absorption-related Processes (UNGAP)" was initiated in 2017, with the aim to improve the current comprehension of intestinal drug absorption and foster future developments in this field. In this regard, in vivo techniques used for the characterization of human GI physiology and the intraluminal behavior of orally administered dosage forms in the GI tract are fundamental to gaining deeper mechanistic understanding of the interplay between human GI physiology and drug product performance. In this review, the potential applications, advantages, and limitations of the most important in vivo techniques relevant to oral biopharmaceutics are presented from the perspectives of different research fields.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article